These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 18237245

  • 1. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.
    Naidu R, Yip CH, Taib NA.
    Neoplasma; 2008; 55(2):87-95. PubMed ID: 18237245
    [Abstract] [Full Text] [Related]

  • 2. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R, Har YC, Taib NA.
    J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
    [Abstract] [Full Text] [Related]

  • 3. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
    Yu CP, Yu JC, Sun CA, Tzao C, Ho JY, Yen AM.
    Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
    Yaylim-Eraltan I, Ergen A, Görmüs U, Arikan S, Küçücük S, Sahin O, Yigit N, Yildiz Y, Isbir T.
    In Vivo; 2009 Jan; 23(5):767-72. PubMed ID: 19779113
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. HER-2 [Ile655Val] polymorphism in association with breast cancer risk: a population-based case-control study in Slovakia.
    Zúbor P, Vojvodová A, Danko J, Kajo K, Szunyogh N, Lasabová Z, Biringer K, Visnovský J, Dókus K, Galajda P, Plank L.
    Neoplasma; 2006 Jan; 53(1):49-55. PubMed ID: 16416013
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
    Bedewy AM, Mostafa MH, Saad AA, El-Maghraby SM, Bedewy MM, Hilal AM, Kandil LS.
    J BUON; 2013 Jan; 18(1):227-38. PubMed ID: 23613410
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk.
    Akisik E, Dalay N.
    Exp Mol Pathol; 2004 Jun; 76(3):260-3. PubMed ID: 15126109
    [Abstract] [Full Text] [Related]

  • 17. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
    Jain M, Kumar S, Lal P, Tiwari A, Ghoshal UC, Mittal B.
    Cancer Detect Prev; 2007 Jun; 31(3):225-32. PubMed ID: 17561354
    [Abstract] [Full Text] [Related]

  • 18. HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis.
    Tao W, Wang C, Han R, Jiang H.
    Breast Cancer Res Treat; 2009 Mar; 114(2):371-6. PubMed ID: 18438707
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A case-control study of the HER2 Ile655Val polymorphism and risk of breast cancer in Taiwan.
    Lee SC, Hou MF, Hsieh PC, Wu SH, Hou LA, Ma H, Tsai SM, Tsai LY.
    Clin Biochem; 2008 Feb; 41(3):121-5. PubMed ID: 18062925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.